AlphaFold predicted structure
ASNS · P08243

Mean pLDDT
94.3/ 100
Very high
561 residues
Confidence breakdown
- Very high(≥ 90)88%
- Confident(70–90)9%
- Low(50–70)2%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
asparagine synthetase (glutamine-hydrolyzing)
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalcongenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome
hereditary disease
Neurodevelopmental delay
Abnormal cerebral morphology
Neurodevelopmental abnormality
cholelithiasis
spinocerebellar ataxia, autosomal recessive 29
multiple sclerosis
colorectal carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
ASNS · P08243

Mean pLDDT
94.3/ 100
Very high
561 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0